Axsome Therapeutics

AXSM • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $74,999 $71,530 $57,794 $46,700
Gross Profit 66,871 64,152 51,262 42,101
EBITDA -66,855 -117,710 -62,120 -57,415
EBIT -68,686 -112,942 -63,727 -59,004
Net Income -68,357 -98,651 -62,199 -67,170
Net Change In Cash 74,999 71,530 57,794 46,700
Cost of Revenue 190,598
Free Cash Flow -53,565 -30,369 -53,919 -55,482
Cash 331,441 386,193 416,564 437,113
Basic Shares 47,393 47,329 47,117 43,669

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $270,600 $50,037 $8,819 $0
Gross Profit 237,701 44,839 -1,155 -77
EBITDA -176,073 -170,936 -123,551 -99,087
EBIT -182,907 -176,500 -124,706 -99,141
Net Income -239,238 -197,766 -134,943 -105,388
Net Change In Cash 270,600 50,037 8,819 0
Cost of Revenue -97,403 -36,089
Free Cash Flow -145,662 -117,212 -108,533 -78,502
Cash 386,193 200,841 86,472 183,876
Basic Shares 45,425 40,655 37,618 37,206

Earnings Calls

Quarter EPS
2024-03-31 -$1.44
2023-12-31 -$2.08
2023-09-30 -$1.32
2023-06-30 -$1.54